(1)
Al-Dughaishi, M.; Shalaby, A.; Al-Ribkhi, K.; Boudaka, A.; Boulassel, M.-R.; Saleh, J. The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated With Neoadjuvant Chemotherapy. Sultan Qaboos Univ Med J 2019, 19, e277-283.